Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 21
- Pharmaceutical
European Cannabis Stocks Review: OCT Announces ‘Budget Review’ As Finance Director Quits, Tikun Olam Cannbit Receives EU GMP & More From IIROC
AFTER a month of relatively positive upwards trajectory for many European cannabis stocks, this week has seen a return to stagnation and decline, although a number of companies have managed to retain their price gains.
- Markets & Stocks
Goodbody Health Announces 1:10 Share Consolidation As It Completes Redomiciliation To Guernsey
GOODBODY Health informed investors this week that it intends to apply a 1:10 ‘reverse stock split’ as it waits for its shares to return to trading on the Aquis Stock Exchange.
- Markets & Stocks
European Cannabis Stocks Review: Chill Brands Becomes Latest UK-Listed Stock To Stage Comeback, IM Cannabis Edges Closer To Delisting, & More From Cellular Goods
THIS week has seen European cannabis stocks once again gain momentum in the face of dismal economic news.
- Pharmaceutical
European Cannabis Stocks Review: LSE-Listed Cannabis Stocks Enjoy Unexpected Comeback As Cellular Goods Jumps 40%
In further signs of positive momentum, UK listed cannabis stocks made an unexpected comeback this week, following months of unrelenting share price losses across Europe.
- Cultivation
Cookies CEO makes history on the cover of Forbes
COVER STAR Cookies CEO makes history on the cover of Forbes Rapper and entrepreneur Berner, the CEO of Cookies, is the first representative of the cannabis industry to appear on the cover of Forbes magazine.
- Markets & Stocks
European Cannabis Stocks Review: SEED Innovations Says Yooma Wellness Has Had A ‘Major Impact’ On Its NAV & MGC Pharma Announces New $10m Financing Agreement
THIS week saw two landmark cannabis reform bills put before US Congress, including the Cannabis Administration and Opportunity Act (“CAOA”) and the Secure and Fair Enforcement Act (SAFE).
- CBD Market
Brittney Griner’s lawyers argue cannabis was prescribed
ON THE DEFENSE Brittney Griner’s lawyers argue cannabis was prescribed WNBA star Brittney Griner’s lawyer argued that in addition to mistakenly bringing a cannabis vape to Russia while packing in a rush, the cannabis product was prescribed for medical purposes, reports the Guardian.
- Adult-Use
Weedmaps accused of promoting ‘black market activity’
BLACK MARKETS SALES Weedmaps accused of promoting ‘black market activity’ Complaints filed to the California Department of Cannabis Control (DCC) and the US Securities and Exchange Commission (SEC) by LA-based Canex Delivery say that Nasdaq-listed cannabis tech company Weedmaps is “allowing vast amounts of black market activity through their website, and they know about it…
- Adult-Use
Schumer commits to making some progress on cannabis this year
BIPARTISAN BILL Schumer commits to making some progress on cannabis this year Senate Majority Leader Chuck Schumer has pledged to get “something” achieved on the cannabis reform file “this year” by taking a bipartisan approach, per Marijuana Moment.
- Markets & Stocks
European Cannabis Stocks Review: MGC Pharma’s Shares Jump Nearly 50% After Long Covid Study, Love Hemp Re-shuffles Boardroom After Months Of Suspension, & More From Akanda
FOLLOWING weeks of widespread losses throughout the European cannabis sector in the wake of ongoing macroeconomic headwinds, this week saw a number of prominent players secure double-digit share price rises.
- Adult-Use
European Cannabis Stocks Review: Kanabo Climbs 25% Following Spanish Medical Legalisation Announcement, DeepVerge Continues Run Of Success
AS Democrats condemn President Joe Biden’s almost complete lack of action on promises to enact cannabis reform at the federal level, progress across the rest of the world has continued at pace this week.
- Pharmaceutical
European Cannabis Stocks Review: Jazz Pharmaceuticals Fails Phase 3 Trail For Sativex, CiiTech Pushes Ahead With IPO Plans
Jazz Pharmaceuticals Jazz Pharmaceuticals, which has become the world’s largest exporter of medical cannabis products since it bought GW Pharmaceuticals for $7.2bn last year, saw its stock price rise this week despite news that its flagship product failed phase 3 trials.
